The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes

Immunocombination therapy for high-risk neuroblastoma

(2012) Michiel Kroesen et al.   Immunotherapy

Tumor-Infiltrating Lymphocytes in Melanoma

(2012) Sylvia Lee et al.   Current Oncology Reports

Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy

(2011) N. Halama et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

(2011) Niels Junker et al.   CELLULAR IMMUNOLOGY

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

(2011) S. A. Rosenberg et al.   CLINICAL CANCER RESEARCH

Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

(2011) Anneleen Decock et al.   Epigenetics

Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients

(2011) I. Poschke et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

(2011) Sahar M.A. Mahmoud et al.   JOURNAL OF CLINICAL ONCOLOGY

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

(2011) Madhu Gowda et al.   Journal of Translational Medicine

Immunology and immunotherapy of neuroblastoma

(2011) Robert C. Seeger   SEMINARS IN CANCER BIOLOGY

Large-scale bioreactor expansion of tumor-infiltrating lymphocytes

(2010) Arian Sadeghi et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer

(2010) Takayuki Iwamoto et al.   JNCI-Journal of the National Cancer Institute

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

(2010) H. Caren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

(2009) Liping Song et al.   JOURNAL OF CLINICAL INVESTIGATION

In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

(2009) Franck Pagès et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy

(2009) Jacob A. Klapper et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Gene-Expression Signatures in Breast Cancer

(2009) Christos Sotiriou et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene

(2008) Helena Caren et al.   BMC GENOMICS

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

(2008) Martin A Pule et al.   NATURE MEDICINE